Navigation Links
Researchers Turn from Drugs to Mini Organs for Diabetes Cure, According to Yasmin Malhotra
Date:3/11/2013

New York, New York (PRWEB) March 11, 2013

Yasmin Malhotra, a writer who has studied the pharmaceutical industry in great detail, is ecstatic to share the news that Diabetes Research Institute, or DRI, may have a cure for Type 1 diabetes in its sights. According to an article published by the Huffington Post, DRI, which is part of the University of Miami, has designed the DRI BioHub. This medical device, which was coined a "mini organ," may allow researchers to cure Type 1 diabetes in just five to seven years, according to the article.

Dr. Camillo Ricordi, who is the scientific director and chief academic officer of DRI, asserts: "It [the DRI BioHub] will mimic the insulin function of a normal pancreas. It will restore natural insulin production for any patient, no matter how long they've had diabetes."

While many members of the general public may have assumed that the cure for diabetes would come in the form of a pharmaceutical drug, the researchers at DRI have pinpointed an alternative method to addressing this condition. The article explains: "The BioHub is an engineered 'mini organ' that will house insulin-producing (islet) cells that, like normally functioning islet cells, sense blood sugar and release the precise amount of insulin to maintain normal blood sugar levels."

If the device is successfully, it means that individuals who suffer from Type 1 diabetes (and, the article asserts, possibly other forms of the disease) can cure the condition with the use of the BioHub. According to the article, the reason why this breakthrough has finally taken place is due to the technological advances that have provided the tools researchers needed to make it happen.

Dr. Ricordi explains: "For the first time we have the convergence of all the different technologies we've been developing over the years, and that we need, those dealing with autoimmunity, cell sources and auto immune suppression, to have a biologic cure."

Yasmin Malhotra encourages researchers to continue on this path in an effort to create a cure that will be applicable to millions of diabetes patients. "Diabetes is a difficult disease to live with, and it can be fatal if not managed correctly," Malhotra states. "But simply managing this condition can be a full-time job for many people. If the BioHub is successful, individuals who suffer from diabetes will be able to finally reclaim their lives."

ABOUT:

[Yasmin Malhotra is a writer who has penned multiple articles on varying topics, including the pharmaceutical industry, globalization, immigration, AIDS, art, and more. A travel enthusiast, Yasmin Malhotra is keen to learn more about new cultures and is particularly fond of surfing. Additionally, Yasmin Malhotra is focused on her efforts in the social work field and is active in the endeavors of many non-profit organizations that support various causes, from senior care to education to providing financial assistance to individuals in need.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10512493.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Researchers develop new tool to eliminate 30-day hospital readmissions in heart failure patients
2. UTHealth researchers say more rapid test for Group B strep successful
3. U of M researchers find wide variation in cesarean delivery rates among US hospitals
4. BUSM researchers use goal-oriented therapy to treat diabetic neuropathies
5. Researchers Describe 1st Functional Cure of HIV in Baby
6. Industry and academic researchers gather for innovative accelerating cancer cures research symposium
7. Researchers describe first functional HIV cure in an infant
8. Researchers discover how to shutdown cancers powerful master protein
9. UGA researchers identify brain pathway triggering impulsive eating
10. Researchers show that lipid nanoparticles are ideal for delivering genes and drugs
11. Researchers at the UH Cancer Center discover protein that may control the spread of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... The National Association of Chain ... in Puerto Rico. Radio messages set to debut on Monday, May 9, and ... about ways to protect themselves and their unborn children from the effects of ...
(Date:5/6/2016)... ... May 06, 2016 , ... DrugDev President and CEO Ibraheem ... pharmaceutical industry conducts clinical trials. This month Ibs was named No. 20 on The ... he was honored as a Tech Disruptor by the Philadelphia Business Journal. , Stephanie ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... Bluvault's Integration Service, their latest implementation service offering for global clients of Coupa ... Appterra ). , Bluvault’s Integration Service is a key component in the ...
(Date:5/6/2016)... ... 06, 2016 , ... From May 4 to 6, EarQ and ... opportunity to learn more about Signia’s technology and the successful business and marketing techniques ... priority to see practices succeed in this highly competitive industry,” said Ed Keller, president ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning plumbing ... operated for over 35 years. Maintaining core values of exceptional customer service, quality work ... made them a leading name in San Diego plumbing, and other services including heating ...
Breaking Medicine News(10 mins):
(Date:5/6/2016)... , May 6, 2016  Hill-Rom Holdings, Inc. (NYSE: ... of Directors declared a fiscal year 2016 third quarter ... percent increase over the amount paid a year ago. ... record as of the close of business on June 10, ...    Hill-Rom is a leading global medical technology ...
(Date:5/5/2016)... Ltd. today reported initial promising results in animal trials of its Zika vaccine candidates. ... ... ... ... Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back to ...
(Date:5/5/2016)... , First quarter 2016 adjusted diluted earnings per share ... , First quarter reported diluted (GAAP) loss per share ... revises 2016 financial guidance; now expects 2016 revenues to range ... non-GAAP earnings per share to range from $4.50 to $4.80 ... and manufacturing facility restructuring , Company expands ...
Breaking Medicine Technology: